Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
Trial details
- Registry ID
- NCT04816604
- Phase
- Phase 2
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)NCT04816604 | Gossamer Bio USA, Inc. | Phase 2 | Terminated | 2026-09-09Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |